Seroba Kernel Life Sciences
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia
Industries Focus
- Healthcare
- HealthTech
- Life Sciences
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Regenerative Medicine
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Therapeutics
- Immunology
- Rare Diseases
- Biopharmaceuticals
- Cell Therapy
- Gene Therapy
Investment Size:
500,000 to 10,000,000 USD
Investor Details Founded: 2009
Seroba Kernel Life Sciences is a prominent European venture capital firm specializing in life sciences investments. The firm is dedicated to creating value by supporting innovative biotech and medtech companies, aiming to improve lives through groundbreaking healthcare technologies. With a strong presence in Ireland and the United Kingdom, Seroba Kernel Life Sciences leverages its deep industry expertise to back entrepreneurs developing world-class businesses around extraordinary science.
The firm's investment strategy encompasses a broad spectrum of stages, from seed to late-stage investments, including Series A, Series B, growth, and pre-IPO rounds. Seroba Kernel Life Sciences focuses on a diverse range of industries within the life sciences sector, such as biotechnology, medical devices, diagnostics, therapeutics, and healthcare. Their geographical focus spans across Europe and the United States, reflecting a commitment to fostering innovation in key global markets.
Seroba Kernel Life Sciences has a proven track record of successful investments, with a portfolio that includes companies like Covagen, a Swiss biotech firm developing novel protein therapeutics, and Deciphex, a leader in AI-powered digital pathology. The firm's approach combines deep scientific knowledge with operational expertise, enabling them to identify and nurture companies with the potential to transform medical care. Their portfolio companies benefit from strategic guidance, operational support, and access to a network of industry experts, positioning them for success in the competitive life sciences landscape.
Requirements
- Innovative life sciences companies with breakthrough technologies
- Strong scientific and operational management teams
- Potential to transform medical care
- Scalable business models with global market potential
- Alignment with Seroba Kernel Life Sciences' investment strategy and focus areas
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Covagen
- Deciphex
- Complement Therapeutics GmbH
- Crescent Diagnostics
- Shorla Oncology
- Azafaros
- Endotronix
- INNOVO by Atlantic Therapeutics
- PQ Bypass
Mentioned In
-
$24.95
-
$19.95
-
$49.95
-
$39.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Seroba Kernel Life Sciences?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim